Integrated BioPharma, Inc. (INBP)

OTCMKTS · Delayed Price · Currency is USD

0.3255

-0.0245 (-7.00%)

Jun 27, 2025, 2:19 PM EDT

Revenue by Product

Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2017 - 2019
Contract Manufacturing	48.57M	Log In	Log In	Log In	Log In	Upgrade
Contract Manufacturing Growth	0.60%	Log In	Log In	Log In	Log In	Upgrade
Other Nutraceutical Businesses	1.75M	Log In	Log In	Log In	Log In	Upgrade
Other Nutraceutical Businesses Growth	-26.97%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2017 - 2019
United States	42.34M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-0.64%	Log In	Log In	Log In	Log In	Upgrade
International	7.97M	Log In	Log In	Log In	Log In	Upgrade
International Growth	-1.02%	Log In	Log In	Log In	Log In	Upgrade